Tibet Weixinkang Medicine Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 207.947 million compared to CNY 129.973 million a year ago. Operating income was CNY 23.278 million compared to CNY 13.439 million a year ago. Net income was CNY 18.555 million compared to CNY 10.939 million a year ago. Basic earnings per share from continuing operations was CNY 0.04 compared to CNY 0.03 a year ago.